1. Home
  2. MBIO vs YCBD Comparison

MBIO vs YCBD Comparison

Compare MBIO & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • YCBD
  • Stock Information
  • Founded
  • MBIO 2015
  • YCBD 2015
  • Country
  • MBIO United States
  • YCBD United States
  • Employees
  • MBIO N/A
  • YCBD N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • YCBD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBIO Health Care
  • YCBD Health Care
  • Exchange
  • MBIO Nasdaq
  • YCBD Nasdaq
  • Market Cap
  • MBIO 7.9M
  • YCBD 1.7M
  • IPO Year
  • MBIO N/A
  • YCBD N/A
  • Fundamental
  • Price
  • MBIO $0.22
  • YCBD $0.44
  • Analyst Decision
  • MBIO Strong Buy
  • YCBD
  • Analyst Count
  • MBIO 1
  • YCBD 0
  • Target Price
  • MBIO $2.00
  • YCBD N/A
  • AVG Volume (30 Days)
  • MBIO 391.7K
  • YCBD 30.3K
  • Earning Date
  • MBIO 11-12-2024
  • YCBD 08-14-2024
  • Dividend Yield
  • MBIO N/A
  • YCBD N/A
  • EPS Growth
  • MBIO N/A
  • YCBD N/A
  • EPS
  • MBIO N/A
  • YCBD N/A
  • Revenue
  • MBIO N/A
  • YCBD $20,636,546.00
  • Revenue This Year
  • MBIO N/A
  • YCBD N/A
  • Revenue Next Year
  • MBIO N/A
  • YCBD $9.38
  • P/E Ratio
  • MBIO N/A
  • YCBD N/A
  • Revenue Growth
  • MBIO N/A
  • YCBD N/A
  • 52 Week Low
  • MBIO $0.13
  • YCBD $0.43
  • 52 Week High
  • MBIO $2.11
  • YCBD $1.73
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 40.01
  • YCBD 38.58
  • Support Level
  • MBIO $0.21
  • YCBD $0.43
  • Resistance Level
  • MBIO $0.24
  • YCBD $0.48
  • Average True Range (ATR)
  • MBIO 0.02
  • YCBD 0.02
  • MACD
  • MBIO 0.00
  • YCBD 0.00
  • Stochastic Oscillator
  • MBIO 20.25
  • YCBD 17.31

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: